MedCity News
FEBRUARY 25, 2024
The way dentistry has embraced technological innovation to make patient care both safer and more comfortable serves as an example for the rest of the healthcare sector.
pharmaphorum
FEBRUARY 25, 2024
TevaU and Alvotech claim first US approval for first biosimilar of AbbVie’s high-concentration Humira, which accounts for 88% of brand prescriptions
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
FEBRUARY 25, 2024
At ViVE 2024, Tarun Kapoor — chief digital transformation officer at New Jersey-based Virtua Health — highlighted a conundrum he thinks may be the reason why AI hasn’t been able to move the needle when it comes to solving the clinician shortage.
Contrarian Sales Techniques
FEBRUARY 25, 2024
I have not made it a ritual to remind others that Ramadan is approaching. That said, observant salespeople are going to add another unique challenge: maintaining their usual level of performance while observing the fast. While the month brings spiritual blessings and a renewed sense of community, adjusting your daily routines can be troublesome. In this blog post, I aim to arm you with practical tips to steer your work schedule during Ramadan without compromising your performance.
MedCity News
FEBRUARY 25, 2024
Providers have an ethical imperative to facilitate a truly informed choice for parents and donors, which means educating them about the facts around anonymous donation, the potential needs of their donor-conceived child, and the importance of choosing programs that dedicate time and effort toward obtaining updated medical information.
MedCity News
FEBRUARY 25, 2024
In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.
Expert insights. Personalized for you.
120 
Let's personalize your content